MyLe Hoang has 22 years of experience in the pharmaceutical industry across various therapeutic areas with in-depth knowledge in clinical data management, trial management, clinical operations, process and quality management, GCP auditing and GCP inspections. MyLe is currently a senior director in the clinical quality assurance (CQA) organization at Eisai where she is the Next Gen Strategy Lead & North America CQA Head. MyLe holds a B.A. in Chemistry from Grinnell College and MS in Organic Chemistry from the University of Illinois at Urbana-Champaign.